Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut Mutualiste Montsouris
About this trial
Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors.
Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors.
Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors
Disqualifiers
none
Trial population
Adults on immune checkpoint inhibitors for cancer treatment
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No intervention for research purposes only
Other interventionNo intervention for research purposes only
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Major cardiovascular event
Composite endpoint: acute coronary syndrome, myocarditis, pericarditis, heart failure, Taki Tsubo, ventricvular arrhymias
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov